MindMaze Therapeutics Holding SA (SIX: MMTX) (MindMaze Therapeutics or the Company), a global leader in scalable precision neurotherapeutics, today published the invitation to its 2026 Annual General ...
GENEVA, CH / ACCESS Newswire / June 2, 2026 / MindMaze Therapeutics Holding SA (SIX:MMTX) (MindMaze Therapeutics or the Company), a global leader in scalable precision neurotherapeutics, today ...
Digital therapeutics specialist MindMaze Therapeutics is selling off a pipeline program whilst also removing all ...
GENEVA, CH / ACCESS Newswire / May 26, 2026 / MindMaze Therapeutics Holding SA (SIX: MMTX ) (MindMaze Therapeutics or the Company), a global leader in scalable precision neurotherapeutics, today ...
Switzerland-based MindMaze has developed a platform designed to help those who are disabled neurologically, mostly stroke victims, recover by re-training their brain with the help of virtual reality, ...
Swiss neurogaming company MindMaze has received FDA clearance for its MindMotion Pro platform, a motion capture system similar to the Microsoft Kinect which can be used in rehabilitation of stroke and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results